📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome. (2022)

First Author: Oriol-Tordera B

Attributed to: Definition and induction of broadly protective responses against HIV-1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2022.103956

PubMed Identifier: 35325780

Publication URI: http://europepmc.org/abstract/MED/35325780

Type: Journal Article/Review

Volume: 78

Parent Publication: EBioMedicine

ISSN: 2352-3964